Fathom Systems Revenue and Competitors

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Fathom Systems's estimated annual revenue is currently $1.7M per year.(i)
  • Fathom Systems's estimated revenue per employee is $87,000

Employee Data

  • Fathom Systems has 19 Employees.(i)
  • Fathom Systems grew their employee count by -5% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$9.7M74-16%N/AN/A
#2
$0.4M6N/AN/AN/A
#3
$0.1M60%N/AN/A
#4
$29M1826%N/AN/A
#5
$0.2M3-40%N/AN/A
#6
$5.1M44-56%N/AN/A
#7
$20.2M86-52%$73.9MN/A
#8
$1.5M176%N/AN/A
#9
$23.9M150-3%N/AN/A
#10
$80.3M4437%N/AN/A
Add Company

What Is Fathom Systems?

Fathom™ represents the next generation in indoor location technology, utilizing Bluetooth to enhance asset tracking and RTLS with 2 meter or better accuracy. Fathom's subscription-based location as a service (LaaS) offering provides greater coverage than RFID, better accuracy than Wi-Fi and at a lower cost than other RTLS systems like ultra-wide band — filling a functional and operational gap between these technologies. #RTLS #IoT #BLE #Assettracking

keywords:N/A

N/A

Total Funding

19

Number of Employees

$1.7M

Revenue (est)

-5%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Fathom Systems News

2022-04-17 - The pharmanauts: how will astronauts produce drugs on deep space missions?

Mars is a long way off. Other planets in the solar system are even more so, as for other solar systems, we can't even fathom visiting them...

2022-04-17 - Consegna buys Fathom to expand long-acting injectable ...

Using the systems, the company is building a pipeline of candidates in therapeutic areas in which LAIs can make a difference, for example by...

2022-04-17 - Consegna Pharma Acquires Fathom Pharma to Strengthen Initiatives that Address the Opioid Crisis

"We are delighted to welcome the Fathom team to Consegna." ... technologies to create long-acting injectable (LAI) drug delivery systems.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$2.3M19N/AN/A
#2
$1.7M19N/AN/A
#3
$1.6M19N/AN/A
#4
$1.2M19-41%$7M
#5
$2.8M19-51%N/A